Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease
Research Article
[키워드] Abnormalities
abnormality
appear
Arrhythmias
assessment
baseline
Blood
caused
changes in
Clinical data
Clinical outcome
coronavirus 2019 disease
coronavirus disease
Course
COVID-19
diarrhea
died
dose
evaluate
failure
grade 3
HCQ
HCQ therapy
highlighting
Hospitalization
hospitalized patient
hospitals
Hydroxychloroquine
hypoxia
IMPROVE
in vitro activity
in-hospital mortality
incident
liver
mechanical ventilation
New York City
occurred
outcomes
Patient
proportion
QT prolongation
randomized trials
receiving
requiring supplemental oxygen
Respiratory Coronavirus
Result
retrospective cohort study
Safe
Safety
SARS-CoV-2
supplemental oxygen
sustained
therapy
Tolerability
tolerable
Treatment
ventricular
vomiting
with COVID-19
worldwide pandemic
[DOI] 10.1371/journal.pone.0236778 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0236778 PMC 바로가기 [Article Type] Research Article